We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$18.2B
AUM Growth
-$235M
Cap. Flow
-$283M
Cap. Flow %
-1.55%
Top 10 Hldgs %
32.02%
Holding
333
New
17
Increased
37
Reduced
36
Closed
22

Top Buys

Rank Stock Value
1
ZEN
ZENDESK INC
ZEN
+$262M
2
CLVT icon
Clarivate
CLVT
+$202M
3
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$196M
4
SPGI icon
S&P Global
SPGI
+$139M
5
HUM icon
Humana
HUM
+$122M

Top Sells

Rank Stock Value
1
COHR
Coherent Inc
COHR
+$154M
2
HWM icon
Howmet Aerospace
HWM
+$140M
3
CSGP icon
CoStar Group
CSGP
+$139M
4
BSX icon
Boston Scientific
BSX
+$116M
5
MANT
Mantech International Corp
MANT
+$92.7M

Sector Composition

Rank Sector Weight
1 Healthcare 28.39%
2 Technology 19.07%
3 Financials 13.73%
4 Industrials 8.28%
5 Communication Services 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BX icon
26
Blackstone
BX
$108B
$261M 1.43%
3,114,951
+293,500
+10% +$28.4M
DT icon
27
Dynatrace
DT
$14.2B
$251M 1.38%
7,202,000
-645,000
-8% -$24.9M
META icon
28
Meta Platforms (Facebook)
META
$1.4T
$245M 1.35%
1,807,040
+26,000
+1% +$4.21M
SJR
29
DELISTED
Shaw Communications Inc.
SJR
$226M 1.24%
9,302,000
-615,000
-6% -$16.3M
NYT icon
30
New York Times
NYT
$10.6B
$225M 1.24%
7,828,073
+947,269
+14% +$29M
SPGI icon
31
S&P Global
SPGI
$127B
$219M 1.2%
717,500
+388,500
+118% +$139M
AON icon
32
Aon
AON
$75.3B
$217M 1.19%
808,486
-120,000
-13% -$33.9M
CSGP icon
33
CoStar Group
CSGP
$13.1B
$206M 1.13%
2,960,185
-2,003,000
-40% -$139M
IBB icon
34
PUT
iShares Biotechnology ETF
IBB
$10.7B
$199M 1.09%
+1,700,000
New +$211M
ADBE icon
35
Adobe
ADBE
$109B
$191M 1.05%
694,772
-16,000
-2% -$6.05M
NOW icon
36
ServiceNow
NOW
$133B
$186M 1.02%
2,467,750
+17,000
+0.7% +$1.53M
BEKE icon
37
KE Holdings
BEKE
$19.6B
$174M 0.96%
9,958,500
– –
BEAM icon
38
Beam Therapeutics
BEAM
$3.07B
$173M 0.95%
3,631,271
+159,000
+5% +$9.07M
EXEL icon
39
Exelixis
EXEL
$13.4B
$167M 0.92%
10,675,844
+501,571
+5% +$9.69M
XYZ
40
Block Inc
XYZ
$49.4B
$142M 0.78%
2,584,000
-255,000
-9% -$18.1M
VMW
41
DELISTED
VMware, Inc
VMW
$125M 0.69%
1,175,623
+165,623
+16% +$19.1M
HUM icon
42
Humana
HUM
$45.5B
$122M 0.67%
+251,200
New +$122M
CVS icon
43
CVS Health
CVS
$119B
$120M 0.66%
1,256,259
+10,000
+0.8% +$990K
UTHR icon
44
United Therapeutics
UTHR
$22B
$115M 0.63%
549,673
+156,977
+40% +$35.1M
HZNP
45
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$110M 0.61%
1,780,223
+687,063
+63% +$48M
LHCG
46
DELISTED
LHC Group LLC
LHCG
$106M 0.58%
650,000
+360,000
+124% +$58.4M
ABBV icon
47
AbbVie
ABBV
$468B
$97.3M 0.53%
725,112
+219,597
+43% +$31.5M
SWCH
48
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$88.6M 0.49%
2,630,000
+300,000
+13% +$10.2M
ALNY icon
49
Alnylam Pharmaceuticals
ALNY
$31.6B
$85.8M 0.47%
428,456
-359,454
-46% -$68.6M
INSP icon
50
Inspire Medical Systems
INSP
$1.8B
$85.5M 0.47%
481,996
+68,996
+17% +$13.9M
1
2
3 4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2022 Portfolio in Review

As of Q3 2022, Thomas Steyer held 333 positions worth $18.2B, down 1.3% from $18.4B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Thomas Steyer's Q3 2022 filing shows 17 new, 37 increased, 36 reduced and 22 closed positions. Its largest new stake was Humana: 251,200 shares worth $122M. The largest sale was Coherent Inc, an estimated $154M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

  • Thomas Steyer's largest Q3 2022 buy was Humana: 251,200 shares worth $122M.
  • Thomas Steyer added most to ZENDESK INC in Q3 2022, an estimated $262M increase.
  • Thomas Steyer's biggest Q3 2022 reduction was Howmet Aerospace, cutting an estimated $140M.
  • Thomas Steyer fully exited Coherent Inc in Q3 2022, selling an estimated $154M.
  • Thomas Steyer's ten largest holdings make up 32% of its $18.2B portfolio in Q3 2022.
  • Thomas Steyer opened 17 new positions and closed 22 in Q3 2022.
  • Thomas Steyer's portfolio value fell 1.3% quarter-over-quarter to $18.2B.

Based on Farallon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.